Hormone therapy and risk for venous thromboembolism: comments and correction.
Waitkevicz
H J
HJ
Axelrod
D
D
D001241:Aspirin / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000517:prevention & control*; D012307:Risk Factors; D020246:Venous Thrombosis / Q000139:chemically induced / Q000517:prevention & control*
D004966:Estrogens, Conjugated (USP); D010975:Platelet Aggregation Inhibitors; D001241:Aspirin